I. Guldvik

发表

Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer

A. Svindland, S. Nygård, E. Richardsen, 2021, Carcinogenesis.

The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells

I. Mills, A. Svindland, A. Bjartell, 2019, Molecular Cancer Research.

A Four-Group Urine Risk Classifier for Predicting Outcome in Prostate Cancer Patients

I. Mills, C. Cooper, R. Ball, 2019 .

Active social citizenship: the case of disabled peoples' rights to personal assistance

K. Christensen, I. Guldvik, M. Larsson, 2014 .

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy

Leslie R Euceda, T. Bathen, A. Svindland, 2017, British Journal of Cancer.

Methodology for the at-home collection of urine samples for prostate cancer detection.

I. Mills, C. Cooper, D. Brewer, 2019, BioTechniques.

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy

Leslie R Euceda, T. Bathen, A. Svindland, 2017, British Journal of Cancer.

Triphenylmethyl Derivatives Enhances the Anticancer Effect of Immunotoxins

Y. Xi, J. Ju, P. Hergenrother, 2011, Journal of immunotherapy.

The β 2 -adrenergic receptor is a molecular switch for 1 neuroendocrine transdifferentiation of prostate cancer cells

A. Svindland, A. Bjartell, A. Urbanucci, 2019 .

Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer

I. Mills, T. Schlomm, P. Tennstedt, 2022, European urology open science.

Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer.

G. Mælandsmo, J. López, Ø. Fodstad, 2022, Pathology, research and practice.

Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies

K. Giercksky, V. Ann Flørenes, K. Flatmark, 2013, International journal of cancer.

Constructing user participation for disabled people—the Norwegian context

I. Guldvik, O. Askheim, 2021, Disability & Society.

Strong and Weak Gender Quota Regimes

I. Guldvik, 2011 .

Disability, social groups, and political citizenship

I. Guldvik, Jon Helge Lesjø, 2014 .

Political citizenship and local political participation for disabled people

I. Guldvik, Vegard Johansen, O. Askheim, 2013 .

The b2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells

I. Mills, A. Svindland, A. Bjartell, 2019 .

Modulation of intracellular calcium homeostasis blocks autophagosome formation

Stefan J. Barfeld, I. Mills, P. Seglen, 2013, Autophagy.

Lipid degradation promotes prostate cancer cell survival

Stefan J. Barfeld, Gregory D. Tredwell, I. Mills, 2017, Oncotarget.

UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation

I. Mills, T. Schlomm, S. Minner, 2014, Oncogene.

O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.

I. Mills, T. Schlomm, S. Minner, 2013, Cancer research.

Towards solidarity: working relations in personal assistance

K. Christensen, I. Guldvik, M. Larsson, 2014 .

Personal assistance: what happens to the arrangement when the number of users increases and new user groups are included?

I. Guldvik, Vegard Johansen, O. Askheim, 2013 .

New Protected Areas in Norway: Local Participation without Gender Equality

O. Vistad, Hanne Svarstad, K. Daugstad, 2006 .

Tumor and Stem Cell Biology O-GlcNAc Transferase Integrates Metabolic Pathways to Regulate the Stability of c-MYC in Human Prostate Cancer Cells

I. Mills, T. Schlomm, S. Minner, 2013 .

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification

H. Grönberg, V. Zuber, I. Mills, 2020, European urology open science.

A differential protein solubility approach for the depletion of highly abundant proteins in plasma using ammonium sulfate.

H. Grönberg, I. Mills, F. Wiklund, 2015, The Analyst.

Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer

A. Kishan, I. Guldvik, A. Stensvold, 2021, Journal of personalized medicine.

Migrant care workers : searching for new horizons

K. Christensen, I. Guldvik, 2014 .

A Four-Group Urine Risk Classifier for Predicting Outcome in Prostate Cancer Patients

I. Mills, C. Cooper, R. Ball, 2019 .

The Ser(186) phospho-acceptor site within ERK4 is essential for its ability to interact with and activate PRAK/MK5.

S. Keyse, O. Seternes, B. Johansen, 2008, The Biochemical journal.

User participation in the Norwegian Welfare Context: an Analysis of Policy Discourses

K. Christensen, I. Guldvik, O. Askheim, 2016, Journal of Social Policy.

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy

Leslie R Euceda, T. Bathen, A. Svindland, 2017, British Journal of Cancer.

Ex vivo metabolic fingerprinting identifies biomarkers predictive 1 of prostate cancer recurrence following radical prostatectomy 2 Running title : Metabolites in prostate cancer predict recurrence 3

T. Bathen, A. Svindland, S. Nygård, 2017 .

A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer

I. Mills, C. Cooper, R. Ball, 2019, BJU international.

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy

Leslie R Euceda, T. Bathen, A. Svindland, 2017, British Journal of Cancer.